Broad-Spectrum Inhibitors of Future Emerging Viruses
Abstract
The goal of our project is to implement a strategy for proactive acquisition of broad-spectrum antivirals against emerging viral pathogens prior to their entry into human populations during outbreaks. If successful, our longer-term goal is to develop broad-spectrum antiviral drugs that can be made available to military and medical personnel at risk of infection during deployment to affected geographical locales. The project addresses three of the FY18 PRMRP Topic Areas. "Emerging infectious diseases" is addressed directly, "vaccine development for infectious diseases" is addressed in spirit though our technology is not a vaccine and, as this project starts by consideration of the flavivirus family, "Guillain-Barre' Syndrome" is relevant since neurotropic species of the virus family are causally associated with GBS.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2021
- Accession Number
- AD1139911
Entities
People
- Antonito T Panganiban